Comparison of Kinesiotaping and Graded Exposure Therapy on Kinesiophobia in Post-Mastectomy Patients
1 other identifier
interventional
32
1 country
1
Brief Summary
The aim of this research is to compare the effect of Comparison of Kinesiotaping and Graded exposure therapy on Kinesiophobia in Post-Mastectomy patients. The sample size was 30. The subjects were divided in two groups, 15 subjects in kinesiotaping group and 15 in graded exposure therapy group. Study duration was of 1 year. Sampling technique applied was nonprobability Convenience sampling technique. Patients had recently undergone mastectomy procedure age between 30 to 60 years and mean Tempa- 11 score of \>23 were included. Tools used in the study are Tempa -11 for kinesiophobia, NPRS for Pain, SPADI for Functional outcome measure. Data was be analyzed through SPSS 26.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2024
CompletedFirst Posted
Study publicly available on registry
October 26, 2024
CompletedStudy Start
First participant enrolled
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 19, 2025
CompletedJuly 3, 2025
July 1, 2025
8 months
October 24, 2024
July 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tempa-11 Scale
Tempa-11 Scale is used to measure Kinesiophobia. This questionnaire has 11 items with the total score of 44, 11 being the lowest possible score and 44 being the highest
Kinesiophobia will be assessed at baseline to 3rd week
Secondary Outcomes (2)
Numeric Pain Rating Scale
Pain will be assessed at baseline to 3rd week
SPADI
it will be assessed at baseline to 3rd week
Study Arms (2)
Experimental: interventional group 1(Kinesiotaping)
ACTIVE COMPARATORKinesiotape will be applied by using two I-bands application technique. It will be applied once a week for 3 to 5 days and total time period of 3 weeks.
Experimental :interventional group II (Graded exposure therapy)
EXPERIMENTALGraded exposure therapy consists of set of exercises, performed for 3 weeks with 3 sessions per week. Each exercise protocol has 5 to 10 repetitions per day.
Interventions
Kinesiotape will be applied by using two I-bands application technique: Short band: to apply this ask the patient to move your arm behind her back as much as possible, then apply kinesiotape at the anterior glenohumeral joint. Longer band: to apply this ask the patient to horizontal adduct her arm as much as possible, than apply kinesiotape targeting the posterior side of glenohumeral joint. Apply both these band with paper-off stretch for 3-5 days or as depending upon skin sensitivity and tape adherence. Kinesiotape will be applied once a week for total time period of 3 weeks.
First week: gentle arm raises with 10 repetitions/day, slow and controlled stretch 25 to 50% force with 5 repetitions, passive internal and external rotations (with towel) with 5 repetitions each/day. Second week: overhead arm raises (wall climbing) with 10 repetitions/day, pendulum exercises 10 repetitions/day, cross arm stretches 5 repetitions/day, active internal and external rotations with 5 repetitions each/day. Third week: resistance exercises (initially with minimum weight or manual resistance), scapular squeezes 10 repetitions/day, gentle chest stretches 5 repetitions/day and gentle stretch with 75 to 100 % force 5 repetitions each/day.
Eligibility Criteria
You may qualify if:
- Females
- Age between 30-60 years.
- Post-Mastectomy patients (not more than 4 weeks).
- Tempa -11 score \>23.
You may not qualify if:
- Any shoulder dislocations/fracture.
- Any known neurological impairments i.e. radiculopathy
- Bilateral mastectomy
- Known Cardiac issues
- Patients undergoing chemotherapy
- Any known allergies to kinesiotaping
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fauji Foundation Hospital
Rawalpindi, Punjab Province, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aisha Razzaq, PhD*
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 24, 2024
First Posted
October 26, 2024
Study Start
November 1, 2024
Primary Completion
June 15, 2025
Study Completion
June 19, 2025
Last Updated
July 3, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share